EIZO Acquires Endoscopy Monitor Business from Panasonic Healthcare for further growth of healthcare business

Published on:

Hakusan, Japan, June, 6th, 2016 – EIZO Corporation (TSE: 6737) announced that it has entered into a definitive agreement with Panasonic Healthcare Co., Ltd. of Japan to acquire Panasonic Healthcare’s endoscopy monitor business.

As a Visual Technology Company, EIZO is expanding its business in specialty markets like healthcare, creative work, and industry by offering a world-leading level of performance and reliability in product development and monitor solutions.

As per the mid-term business plan which EIZO announced in 2015, one of EIZO’s priorities is to expand its business in the healthcare market with a particular focus on the field of operating rooms.

Since August, 2010, Panasonic Healthcare has been developing its endoscopy monitor business. The company has built strong partnerships globally with manufacturers of endoscopy and other medical equipment and its products are in wide use in operating rooms around the world.

By this acquisition, EIZO can provide a complete lineup of endoscopy monitors including 3D and 4K. In addition, integrating the technologies of both companies gives EIZO a significant competitive advantage in product development for accelerating the growth of its healthcare business.

EIZO is a registered trademark of EIZO Corporation.

About EIZO

EIZO (TSE:6737), which means image in Japanese, is a visual technology company that develops and manufactures high-end display solutions. EIZO integrates hardware and software technologies with consulting, web hosting, and other services to help customers in business, creative work,  gaming, medicine, maritime, air traffic control, and other fields work more comfortably, efficiently, and creatively. Headquartered in Hakusan, Japan, EIZO has R&D and manufacturing facilities in Japan, China, Germany, and the US, and representation in more than 80 countries.

Related Content

Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
FDA clears AI screening tool for cardiac amyloidosis
Global shortage of nuclear imaging isotopes may be over
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
FDA clears AI tool that flags signs of heart disease in chest CT scans
AI-enabled plaque assessments help cardiologists ID high-risk CAD patients

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.